Symptom provocation studies in psychiatric disorders: scientific value, risks, and future (Q33760635)

29 July 2017

1 reference

title

Symptom provocation studies in psychiatric disorders: scientific value, risks, and future (English)

1 reference

29 July 2017

D'Souza DC

1

1 reference

29 July 2017

Berman RM

series ordinal

2

1 reference

29 July 2017

Krystal JH

series ordinal

3

1 reference

29 July 2017

Charney DS

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

29 July 2017

Biological Psychiatry

1 reference

29 July 2017

46

1 reference

29 July 2017

8

1 reference

29 July 2017

1060-1080

1 reference

The conjunctival provocation test model of ocular allergy: utility for assessment of an ocular corticosteroid, loteprednol etabonate

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Receptor activity and turnover of dopamine and noradrenaline after neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Symptoms, signs, and diagnosis of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

The Antagonism of Amphetamine-Induced Symptomatology by a Neuroleptic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Partial improvement in negative schizophrenic symptoms after amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Amphetamine response and relapse risk after depot neuroleptic discontinuation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Comparative psychotomimetic effects of stereoisomers of amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Catecholamine regulation of the prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Clinical use of atrial pacing test in angina pectoris.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Experimental rhinovirus infection in volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Relationship between histamine and physiological changes during the early response to nasal antigen provocation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

The experimental reproduction of amphetamine psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Transient Depressive Relapse Induced by Catecholamine Depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Early intervention in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

The electrocardiogram during exercise. Findings in bipolar chest leads of 1,449 middle-aged men, at moderate work levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Catecholamines and mania: The effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Studies of Alpha-methyl-para-tyrosine, L-dopa, and L-tryptophan in Depression and Mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Norepinephrine in depressive reactions. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Differential response to amphetamine in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Inhaled corticosteroid improves bronchial reactivity and decreases symptoms in patients with mitral stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

The biochemistry of affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

7 January 2021

Dissociative Anesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

The glutamatergic dysfunction hypothesis for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

A randomised controlled trial of prophylactic neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Dopamine in schizophrenia: a review and reconceptualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Evolving behavior in the clinical and experimental amphetamine (model) psychosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Fructose-sorbitol malabsorption and symptom provocation in irritable bowel syndrome: relationship to enteric hypersensitivity and dysmotility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Effect of patient characteristics on the yield of prolonged baseline head-up tilt testing and the additional yield of drug provocation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Maintenance antipsychotic therapy: is the cure worse than the disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Effect of inhaled salmeterol on sulfur dioxide-induced bronchoconstriction in asthmatic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Dextroamphetamine. Evaluation of psychomimetic properties in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Concepts of myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Interactive effects of subanesthetic ketamine and haloperidol in healthy humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Increased dopamine transmission in schizophrenia: relationship to illness phases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Regional brain abnormalities associated with specific syndromes of persistent schizophrenic symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Provocative tests with psychostimulant drugs in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Methylphenidate challenge as a predictor of relapse in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Prediction of relapse in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Dopaminergic mechanisms in idiopathic and drug-induced psychoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Predictors of response to high dose antipsychotics in chronic schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Model psychoses and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Maximal treadmill exercise electrocardiography. Correlations with coronary arteriography and cardiac hemodynamics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Provocation of latent left ventricular outflow tract gradients with amyl nitrite and exercise in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Effects of tryptophan depletion in drug-free adults with autistic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

EPPIC: an evolving system of early detection and optimal management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Effects of alpha-methyl-para-tyrosine (AMPT) in drug-free depressed patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Selective cine coronary arteriography correlated with the hemodynamic response to physical stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain. Effect of some phenothiazine analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Glutamate receptor dysfunction and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Clinical reactions of schizophrenics to sodium amytal, pervitin hydrochloride, mescaline sulfate, and d-lysergic acid diethylamide (LSD25)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Stereotyped activities produced by amphetamine in several animal species and man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Postexercise electrocardiogram in arteriosclerotic heart disease. Its value in diagnosis and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Tryptophan depletion and attenuation of cue-induced craving for cocaine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Frequency of life-threatening complications associated with exercise testing (author's transl)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

The catecholamine hypothesis of affective disorders: a review of supporting evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Calcium action potentials restricted to distal apical dendrites of rat neocortical pyramidal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Parachlorophenylalanine Reversal of Tranylcypromine Effects in Depressed Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Symptom provocation of fluoroscopically guided cervical nerve root stimulation. Are dynatomal maps identical to dermatomal maps?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Relapse of depression after rapid depletion of tryptophan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Catecholamines in the brain as mediators of amphetamine psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

National survey of exercise stress testing facilities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

D-serine added to antipsychotics for the treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Long-term pimozide pretreatment differentially affects behavioral responses to dextroamphetamine in schizophrenia. Further exploration of the dopamine hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Antipsychotic effects of pimozide in schizophrenia. Treatment response prediction with acute dextroamphetamine response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Midodrine: a role in the management of neurocardiogenic syncope.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Acute tryptophan depletion and increased food intake and irritability in bulimia nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

The effort test in angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Studies of electrocardiographic changes during exercise (modified double two-step test)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

The initial prodrome in psychosis: descriptive and qualitative aspects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

Specific [3H]phencyclidine binding in rat central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900209-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(99)00209-7

1 reference

29 July 2017

1 reference